Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease
The company is moving its headquarters from Singapore to Boston alongside the capital raise.
The company is moving its headquarters from Singapore to Boston alongside the capital raise.
The funding round was led by insurer Principal Life with participation from the venture arms of large carriers including AXA, MassMutual, Aflac, Transamerica and Wells Fargo.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.